[123i]-Nátrium-Jodid Curium Netherlands

Sodium Iodide (123 I) is a radiopharmaceutical used in nuclear medicine imaging. It helps visualize thyroid function and detect abnormalities. This EU-sourced product is administered intravenously for diagnostic purposes. Suitable for patients requiring thyroid imaging or related assessments.

Sodium Iodide (123 I) is primarily used in diagnostic imaging to evaluate thyroid function and structure. It may also assist in identifying thyroid nodules, hyperthyroidism, or other thyroid-related disorders. This radiopharmaceutical is commonly employed in nuclear medicine scans to provide detailed images of the thyroid gland.

After administration, Sodium Iodide (123 I) emits gamma radiation that is detected by imaging equipment to produce detailed pictures of the thyroid. Patients may experience mild discomfort at the injection site, but the effects are generally transient. The radiotracer is cleared from the body over time, typically within hours to days.

Sodium Iodide (123 I) should be handled by trained medical professionals in a controlled environment. Patients with known iodine allergies or thyroid disorders should inform their healthcare provider before use. Pregnant or breastfeeding individuals should avoid this product unless medically necessary, as radiation exposure may pose risks.

Certain medications, such as thyroid hormones or iodine-containing supplements, may interfere with the uptake of Sodium Iodide (123 I). Patients should disclose all current medications to their healthcare provider. Alcohol and other substances are generally not known to interact, but specific guidance should be sought from a medical professional.